Veritas Pharma Enters into Definitive Agreement to Acquire Indigenous Bloom Hemp Corporation


Ryan Allway

September 10th, 2020

News, Top News


Vancouver, British Columbia–(Newsfile Corp. – September 9, 2020) – Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VPA) (“Veritas” or the “Company“) is pleased to announce that it has entered into a business combination agreement dated September 4, 2020 (the “Business Combination Agreement“) to acquire Indigenous Bloom Hemp Corporation (“HempCo“) by way of a three cornered amalgamation pursuant to the provisions of the Canada Business Corporations Act. The transaction is at arm’s length and constitutes a “fundamental change” under the policies of the Canadian Securities Exchange (the “CSE“).

HempCo operates a large-scale industrial hemp farm in Southern Manitoba on approximately 347 acres of zoned farmland. The primary business of Hempco is the sale of hemp biomass, flower and phytocannabinoid rich extracts derived from the hemp biomass. Currently, Hempco is operating under a third-party cultivation license. However, HempCo has applied to Health Canada for its own license and will transition to that license once approved. HempCo’s first hemp harvest is expected to be completed in October of this year. As of June 15, 2020, HempCo had current assets of $558,160 (unaudited) and current liabilities of $836,295 (unaudited). Veritas obtained an independent third party valuation which concluded that the fair market value of the Hempco shares on April 30, 2020 was in the range of $23,000,000 to $28,000,000.

Veritas interim CEO and CFO, Mr. Peter McFadden, commented, “It has been a long process, but we are now very excited to announce that we have executed the definitive agreement with Indigenous Bloom Hemp Corporation, which expects its inaugural hemp harvest to start in October of this year.”

The following is a summary of the terms of the Business Combination Agreement:

  1. HempCo will amalgamate (the “Amalgamation“) with a wholly-owned subsidiary of Veritas and, upon completion of the Amalgamation, the amalgamated corporation will be a wholly-owned subsidiary of Veritas, will continue the business of Hempco and will be named “Indigenous Bloom Hemp Corporation”.
  2. Veritas will consolidate its common shares on a one post-consolidation share for two pre-consolidation shares basis (the “Consolidation“) and, as consideration for the Amalgamation, Veritas will issue to the shareholders of Hempco post-consolidation common shares having an aggregate value of $28,000,000 at a deemed price per share equal to the closing price of the Veritas shares on the CSE on the last trading day prior to the effective date of the Amalgamation.
  3. The closing of the Amalgamation is subject to a number of conditions precedent, including conditional acceptance for filing by the CSE, approval of the Amalgamation and Consolidation by the shareholders of Veritas and approval of the Amalgamation by the shareholders of Hempco.
  4. The effective date of the Amalgamation is expected to occur within five business days following the satisfaction or waiver of all the conditions precedent contained in the Amalgamation Agreement.
  5. All post-consolidation common shares held by the principles of Veritas following the completion of the Amalgamation will be held in escrow for a period of 36 months, and will released from escrow as to 10% of the post-consolidation shares on the date the shares commence trading on the CSE following completion of the Amalgamation and as to 15% every six months thereafter.
  6. Upon completion of the Amalgamation, the new board of directors and management of Veritas will be as follows:
Name Title
Peter McFadden Interim CEO and CFO
Mark Roseborough Chairman of the Board
Nick Standish Director
Blair Lowther Director
Sharon Blady Director
Howard Ash Director
Greg Van Wyk Director

To the knowledge of the Company, Michael Matvieshen of Kelowna, British Columbia is the only person who beneficially owns, or controls or directs, directly or indirectly, more than 10% of the issued and outstanding shares of Hempco. No person is expected to own more than 20% of the issued and outstanding post-consolidation common shares of Veritas on completion of the Amalgamation.

About Veritas Pharma

Veritas Pharma Inc. has developed intellectual property relating to various cannabis strains. The Company’s goal is to advance the science behind medical cannabis, by developing the most effective cannabis based treatments for specific disease conditions and to acquire income producing assets in the cannabis industry. The Company’s mission is to commercialize its proprietary cannabis products. In addition, Veritas aims to utilize its expertise to enter into mergers and acquisitions with various cannabis industry participants in order to fulfil its goal of revenue generation by the end of the second quarter of 2020.

Veritas Pharma Inc. is a publicly traded company in Canada, on the Canadian Securities Exchange under the ticker VRT; in the United States, on the OTC under the ticker VRTHF; and in Germany, on the Frankfurt exchange under the ticker 2VP.

For more information, please visit our website: veritaspharmainc.com

On behalf of the Board of Directors

Peter McFadden”
Peter McFadden
Interim Chief Executive Officer & CFO

Further information about the Company is available on our website at www.veritaspharmainc.com or under our profile on SEDAR at www.sedar.com, and on the CSE website at www.thecse.com.

Investor and Public Relations Contact

Veritas Pharma Inc.
Telephone: +1.416.918.6785
Email: [email protected]
Website: www.veritaspharmainc.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading